ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Four Win 1988 General Motors Cancer Prizes

June 17, 1988

First Formal CREG Guidelines, Rules Publishes

June 6, 1975

Chest X-Ray Produces Many False-Positive Results

January 27, 2006

DCPC Advisors OK PA On cancer Control In Disadvantaged

June 14, 1991

Breast Density As Important As Age In Determining Risk

September 29, 2006

CPSC Relies On NCI Findings For New Policy

July 21, 1978